Abstract-Clinical studies have suggested that quinidine is less effective when used for the treatment of atrial arrhythmias in pediatric patients compared with its clinical effectiveness in the adult patient population. Age-related changes in the cardiac actions of quinidine on action potential duration and interaction with potassium channels in several mammalian species also have been reported. We investigated the effects of postnatal development on quinidine's interaction with major repolarizing currents (I to , I Kur , I ns , and I K1 ) in human atrial myocytes, using the whole-cell configuration of the voltage-clamp technique. Our results indicate that there are age-related changes in both the IC 50 for quinidine blockade of I to , as well as the mechanism of quinidine unblocking. In contrast, quinidine was found to inhibit both adult and pediatric I K1 and I Kur in an age-independent manner, whereas the nonselective cation current (I ns ), which contributes to the sustained outward current (I sus ), was insensitive to quinidine. The results from this study help to clarify the electrophysiological mechanism by which quinidine elicits its antiarrhythmic effect in the pediatric and adult human population. (Circ Res. 1998;83:1224-1231.)
Q uinidine is one of the most commonly used drugs for treatment of both atrial and ventricular rhythm disturbances. 1 Quinidine's efficacy as an antiarrhythmic agent is believed to result from its effects on conduction velocity and repolarization of the cardiac action potential. 1, 2 Quinidine's ability to prolong the duration of the cardiac action potential has been attributed to its ability to inhibit several different types of potassium ion channels expressed in mammalian cardiac tissue, including the transient outward K current (I to ), the inwardly rectifying K current (I K1 ), the rapidly activating delayed rectifier (I Kr ), and the ultrarapid delayed rectifier (I Kur ). 3 However, the mechanisms by which quinidine exerts its inhibitory effects on these potassium currents are not understood fully.
Previous studies in dog, rabbit, and rat cardiac tissue have documented that the ability of quinidine and other antiarrhythmic agents to alter conduction and repolarization change significantly during postnatal development. 4 -8 Quinidine has been shown to prolong both the QT interval 9 and repolarization 4 of the Purkinje fiber action potential to a significantly greater extent in young canines compared with adult animals. Recent evidence suggests that developmental changes in the effects of antiarrhythmic agents on cardiac tissue may be attributed to age-related changes in drug-channel interactions. 6 -8 For example, quinidine block of rabbit ventricular I to and I K1 has been shown to be significantly different in neonatal versus adult myocytes, with cells from neonates being more sensitive to the action of quinidine than adults. 8 It seems likely that age-related differences in quinidine interaction with cardiac ion channels may also exist in man. Recent clinical studies have documented that quinidine and flecainide exhibit a markedly reduced clinical efficacy against atrial tachyarrhythmias in pediatric patients 10 compared with their relatively high clinical efficacy in adults. 11 Because changes in drug-channel interaction have been indicated as a potential mechanism underlying postnatal changes in the actions of antiarrhythmic agents, we initiated a study to compare the effects of quinidine on major repolarization currents (I to , I K1 , I Kur , and the nonselective cation current, I ns ) expressed in pediatric and adult human atrial myocytes.
Materials and Methods

Human Atrial Specimens and Isolation of Cardiac Myocytes
Human myocytes used in the experiments investigating the effects of quinidine on human atrial potassium channels were isolated from specimens of right atrial appendages obtained during surgery from the hearts of 23 adult patients (35 to 75 years of age) and 17 pediatric patients (4 days to 2 years of age) undergoing cardiopulmonary bypass surgery. Atrial tissue obtained from a separate group of patients was used to study the effects of age on I to density (Figure 1 ).
Atrial tissue was obtained in accordance with Tulane University School of Medicine institutional guidelines. Specimens of atrial tissue were considered free from pathology if all of the following criteria were met: (1) the specimen appeared grossly normal on removal; (2) there was no evidence of right atrial enlargement (eg, P wave amplitudes Ͼ2.5 mm); and (3) there was no evidence for significant right atrial pressure overload (right atrial pressure Ͼ7 mm Hg). Human atrial myocytes were isolated enzymatically from the obtained specimens. The isolation procedure was identical to that previously described by Crumb et al 12 and typically produced an initial yield of 40% to 60% rod-shaped, calcium-tolerant cells. Cells were used within 8 hours after isolation. Currents were recorded from myocytes with characteristically normal morphology (rod-shaped, clear striations, no surface blebs).
Solutions and Drugs
Recordings of potassium currents were made from myocytes bathed in an "external" solution having the following chemical composition (in mmol/L): NaCl 137, KCl 4, MgCl 2 1, CaCl 2 1.8, glucose 11, and HEPES 10 (adjusted to pH 7.4 with NaOH). All recordings were made in the presence of 0.2 mmol/L CdCl 2 to block the L-type calcium current (I Ca ). 13 In most of the experiments, cells were held at -40 mV to inactivate the fast inward sodium current (I Na ). In some cells, I to was elicited with depolarizing steps from a holding potential of -80 mV. As demonstrated by Li and Keung, 14 no sodium current was elicited under these conditions, suggesting complete inactivation of Na channels. Glass pipettes were filled with "internal" solution containing (in mmol/L): K-aspartate 120, KCl 20, Na 2 -ATP 4, EGTA 5, and HEPES 5 (adjusted to pH 7.2 with KOH). When the nonselective cation current was recorded, a potassium-free internal solution of the following composition was used (in mmol/L): CsCl 140, Na 2 -ATP 4, Mg 2 Cl 1, EGTA 5, and HEPES 5 (adjusted to pH 7.2 with CsOH). Quinidine hydrochloride was obtained from Sigma Chemical Co and dissolved in ethanol to form stock solutions of 8-, 40-, and 125-mmol/L concentrations. Pilot experiments indicated that the level of ethanol present in the quinidine stock solution was without effect on ionic currents when added to the bath alone. Steady-state drug effects were typically reached 8 to 10 minutes after onset with quinidine-containing solution. All experiments were performed at room temperature (22°C to 24°C).
Voltage-Clamp Technique and Data Acquisition
The whole-cell patch-clamp technique was used to record ionic currents under voltage-clamp. 15 An Axopatch amplifier (Axon Instruments) interfaced via a 333-kHz Digidata 1200 acquisition board to a personal computer running pClamp (Version 6.0ϩ) software was used to voltage-clamp the isolated myocytes. Borosilicate glass pipettes were made using a horizontal pipette puller, and pipette tips were heat-polished. Pipette tip resistance was Ϸ1 to 2.5 M⍀ when the electrodes were filled with the internal solution.
Capacitative transients were evoked by a 10-mV step (from Ϫ40 to Ϫ50 mV) and well described by a single exponential function. Before compensation, the mean rec of transient decay was estimated to be 0.32Ϯ0.02 ms in adult (nϭ96) and 0.11Ϯ0.01 ms in pediatric cells (nϭ57). Cell capacitance (C m ) was obtained by integration of the area under the capacitative transient. Mean values of C m obtained by this method were 90.2Ϯ3.14 pF and 35.7Ϯ1.07 pF for adult and pediatric myocytes, respectively. The series resistance (R s ) for the pathway between the pipette and cell membrane was estimated from the equation R s ϭ/C m . The uncompensated R s was 3.53Ϯ0.12 M⍀ for adult and 3.1Ϯ1.01 M⍀ for pediatric cells. To minimize the duration of the capacitative surge and voltage drop across the pipette, R s was compensated electronically (typically by 30% to 60%). The amplitude of I to always was measured as the difference between the peak current and the steady-state level of current remaining at the end of the pulse (typically of 800-ms duration). To determine the effects of quinidine on the inwardly rectifying potassium current (I K1 ) and the sustained current (I sus ), a p/4 post hoc leak subtraction procedure was used.
Statistics and Data Analysis
Data are presented as meanϮSEM. Data analysis and curve fitting were performed using the software packages Clampfit (pClamp software, Axon Instruments), Origin (Microcal Software), and Figure 1 . Effect of age on I to density and sensitivity to quinidine. A, Effect of age on I to density. Patients were divided into 9 age groups as shown. I to was elicited by an 800-ms pulse to 60 mV from a holding potential of Ϫ40 mV. I to was corrected for the sustained current. A significant increase in I to density occurred after the second year of life. I to underwent a significant maturational increase (from 4.2Ϯ0.4 pA/pF in patients 1 to 2 years old to 6.97Ϯ0.5 pA/pF in patients 2 to 2.5 years old) during the second year of life. At 11 years, human atrial I to density (9.4Ϯ0.7 pA/pF) did not appear to be different from the density of the current recorded from patients Ͼ11 years old (9.01Ϯ0.5 pA/pF). B, Effect of age and quinidine on I to . Currents were elicited by an 800-ms pulse to 60 mV from a holding potential of Ϫ70 mV. Inserts show typical examples of the effect of 10 mol/L quinidine on the time course and peak amplitude of I to in a pediatric and adult atrial myocyte. Graph shows the relationship between quinidine concentration and inhibition of peak I to . Values indicate meanϮSE. Number of cells is given by each mean value. Average data were fit by the equation: 1/(1ϩ (IC 50 /X) N ). Estimated values for adult I to were IC 50 ϭ21.8 mol/L, Nϭ0.67. For pediatric I to , the values were IC 50 ϭ112.2 mol/L, Nϭ0.82. There was a significant developmental difference in the percentage of quinidine-induced inhibition by 10 and 100 mol/L of the drug, with pediatric I to inhibited to a smaller extent (adult: 37Ϯ4% at 10 mol/L, 75Ϯ1.7% at 100 mol/L; pediatric: 17Ϯ4% at 10 mol/L, 47Ϯ9% at 100 mol/L). IC 50 values for adult and pediatric populations were significantly different (PϽ0.0001). *PϽ0.05 vs all groups Ͻ2 years old; **PϽ0.05 vs all groups Ͻ6 years old.
GraphPad Prism (GraphPad Software, Inc). Differences between group means were evaluated for statistical significance using Student t test. An unpaired t test was used to compare statistically best-fit values of the drug concentration producing 50% inhibition (IC 50 ) of adult and pediatric I to , I sus , and I K1 (GraphPad Prism).
Results
Effect of Postnatal Development on I to Amplitude
In a previous study, it was reported that there is an age-related difference in human atrial I to density, with pediatric current having half the density of the adult I to . 12 Because the time course over which I to undergoes its developmental change was not well defined, we compared values of I to amplitude obtained for 9 different age groups ranging in age between 0 to 1 month and 56 to 75 years. As demonstrated in Figure 1A , the amplitude of human atrial I to did not change significantly during the first 2 years of life, after which it doubled in amplitude between the ages of 2 and 11 years and then remained relatively constant until at least 75 years of age.
Affinity of Adult and Pediatric I to for Quinidine
To define the age-dependent change in quinidine's effect on human I to , cells from the 2 age groups were exposed to 5 different concentrations of quinidine (1, 3, 10, 100, and 1000 mol/L), and dose-response curves for quinidine's effect on the peak I to were constructed ( Figure 1B is the concentration of quinidine, IC 50 is the quinidine concentration producing a 50% inhibition of I to , and N is the Hill coefficient. The least squares best-fit parameters for pediatric inhibition of peak I to were IC 50 ϭ112.2 mol/L and Nϭ0.82. For adult cells, the values were IC 50 ϭ21.8 mol/L and Nϭ0.67. Comparison of the IC 50 values obtained for the 2 age groups using a t test (GraphPad Prism) indicated that pediatric I to was significantly less sensitive to quinidine than were adult cells (PϽ0.0001).
In addition to decreasing I to density, quinidine also accelerated the rate of I to decay in both adult and pediatric cells ( Figure 1B) , a behavior suggesting that channel block develops after channel opening. 16 In both the absence and presence of quinidine, the decaying phase of I to was well fit by a single exponential function for the 2 age groups. The effect of quinidine on current decay kinetics was concentrationdependent but age-independent. At 60 mV, the rec of I to decay in adult cells was decreased from 77.7Ϯ5 ms (nϭ12 to 14) under control conditions to 41.3Ϯ1.4 ms (nϭ5 to 7), 22.4Ϯ3.1 ms (nϭ12 to 14), and 14.6Ϯ2 ms (nϭ5 to 8) in the presence of 1, 3, and 10 mol/L quinidine, respectively. Quinidine produced a similar reduction in the rec of I to decay in pediatric cells. Under control conditions, the rec for decay at 60 mV was 64.5Ϯ5.4 ms (nϭ15 to 18), which decreased during exposure to 1, 3, and 10 mol/L quinidine to 39.6Ϯ5.2 ms (nϭ5), 18.5Ϯ1.4 ms (nϭ5 to 7), and 20.1Ϯ2.4 ms (nϭ5), respectively.
A drug-induced reduction in peak current amplitude could result from a drug-induced shift in voltage dependence of inactivation, as well as open channel block. Equilibration in the presence of 10 mol/L quinidine for 8 to 10 minutes resulted in a hyperpolarizing shift in the midpoint for I to inactivation by 7.9Ϯ1.9 mV in pediatric cells (nϭ6) and 9Ϯ1.9 mV in adult cells (nϭ11). However, the amplitude of the shift in the midpoint was not significantly different from the amplitude of the spontaneous shift observed for cells exposed to quinidinefree solutions for the same time interval (at 1 to 5 minutes, V mid ϭϪ22.9Ϯ1.3 mV; at 20 to 25 minutes, V mid ϭϪ32.7Ϯ1.7 mV). This suggests that quinidine itself does not produce a significant shift in the voltage dependence of inactivation and that the change in the midpoint of the inactivation curve measured during quinidine perfusion is due to perfusion (time) alone. The slope of adult and pediatric voltage dependence of I to inactivation was not affected by quinidine either (adult: nϭ8, control kϭϪ5.2Ϯ0.2 mV, 10 mol/L quinidine kϭϪ6.1Ϯ0.3 mV; pediatric: nϭ6, control kϭϪ6.3Ϯ0.6, 10 mol/L quinidine kϭϪ7.8Ϯ1.5 mV).
Voltage Dependence of I to Recovery From Quinidine Block
Recovery from quinidine block was defined using a pairedpulse protocol (Figure 2A ). Channel block was initially produced using an 800-ms-long pulse, and the time course for recovery from block then was defined using a second pulse evoked after a variable recovery time, ranging from 3 to 8000 ms. Under drug-free conditions, the recovery of channels from inactivation at Ϫ40 mV could be well described by a single exponential equation having a rec significantly smaller in adult cells (292Ϯ27 ms) compared with pediatric cells (450Ϯ49 ms; Figure 2A through 2C) . This difference in rec decreased progressively as the recovery potential was made more hyperpolarized, with rec becoming nearly identical at Ϫ80 mV (adult, 62Ϯ5 ms; pediatric, 71Ϯ7 ms; Figure  2C ). In the presence of quinidine, the recovery of I to from block was a double-exponential process (Figure 2A and 2B). The fast rec was similar to the recovery rec observed during control conditions and was assumed to reflect the recovery of drug-free channels from inactivation. The rec for the slow phase of I to recovery observed in quinidine ( quin ) was assumed to reflect the time course of quinidine unbinding from channels. Pediatric I to was found to recover significantly slower from quinidine block at Ϫ40 mV ( quin ϭ2938Ϯ454 ms) compared with adult channels ( quin ϭ1628Ϯ187 ms; PϽ0.007; Figure 2D ). We also observed a marked developmental difference in the voltage dependence of the rec for quinidine unblocking. In adult cells, the unblocking rec increased significantly with hyperpolarization from Ϫ40 to Ϫ80 mV, whereas in pediatric cells, the unblocking rec underwent an apparent, although not statistically significant decrease with hyperpolarization ( Figure 2D ). The marked difference in voltage sensitivity suggests that the mechanisms for quinidine unblocking are different in pediatric versus adult myocytes. The voltage dependence for quinidine unblocking ( Figure 2D ) in both age groups was also signifi-cantly different from that observed for recovery from channel inactivation under control conditions. In the absence of quinidine, the recovery rec changed e-fold (Ϸ2.7) for a 10.7-mV change in the membrane potential for pediatric cells and e-fold for every 12.6 mV for adult I to ( Figure 2C ). In contrast, quin changed by Ͻ20% over a 40-mV voltage range in pediatric cells and displayed a voltage dependence opposite of control rec in adult cells. This suggests that the mechanism underlying the slow interpulse recovery of I to in the presence of quinidine does not result from a simple slowing of recovery from inactivation.
Effects of Quinidine on I K1 , I sus , and I ns
Previous work by Wang et al 17 reported that quinidine significantly suppressed the sustained current left after inactivation of I to with an estimated IC 50 of 5 mol/L. Initial experiments suggested that this sustained current (designated I Kur ) resulted from the expression of the gene Kv1.5. 18 However, it was found later that the sustained outward current (I sus ) is carried by a combination of at least 2 currents (Ϸ70% I Kur and Ϸ30% by a nonselective current, I ns ). 19 Figure  3A and 3B shows the effect of 100 mol/L quinidine on the total steady-state current. The steady-state current measured at the end of an 800-ms pulse to 60 mV was suppressed by 57Ϯ6% in the presence of 100 mol/L quinidine. The quinidine-sensitive (difference) current was an outwardly rectifying current ( Figure 3B , inset), suggestive of a selective blockade of I Kur . To further test this hypothesis, we defined the effect of quinidine on the nonselective cation current (I ns ) using potassium-free (cesium-containing) pipette solutions, an experimental condition that rapidly eliminated other K-selective currents (eg, I K1 , I Kur , and I to ), allowing us to define selectively quinidine's effect on I ns . As demonstrated in Figure 3C , I to was abolished within 3 minutes after rupturing the membrane when using a pipette filled with potassium-free solution. The current left represented the nonselective cation current. 19 As shown in Figure 3C and 3D, 100 mol/L quinidine had no definable effect on I ns . This supports the conclusion that quinidine's inhibitory effect on the total steady-state current ( Figure 3B ) is exclusively due to quinidine-induced block of I Kur , whose density is known not to be age-independent. 12 Dose-response curves defining the inhibitory effect of quinidine on the total sustained outward current (I sus ϭI Kur ϩI ns ) in pediatric and adult myocytes also were defined from measurements of quinidine's effect on the sustained current at the end of an 800-ms pulse during a step to 60 mV. The IC 50 values obtained after fitting the data to the Hill equation were not significantly different between the 2 age groups (adult IC 50 ϭ6.6 mol/L; pediatric IC 50 ϭ5.1 mol/L; PϾ0.76). Similarly, the maximal level of inhibition of the steady-state current by quinidine was Ϸ70% for both age groups, which is consistent with previous observations that Ϸ70% of the total sustained outward current is carried by I Kur and that the amplitude of I ns is age-independent. 19 Previous work by Wu et al 7 in rabbit myocytes has shown that age-related changes in the sensitivity of I K1 to quinidine may also occur. Although no developmental change in the characteristics of I K1 has been reported for human cardiac tissue, 12 it was difficult to rule out the possibility that postnatal changes in I K1 sensitivity to quinidine sensitivity may not also exist in human tissue. To define the effects of Comparison of the kinetics and voltage dependence of I to recovery from quinidine block in pediatric and adult myocytes. As illustrated in the inset of (A), steady-state level of block was produced by an 800-ms-long pulse to 60 mV. The conditioning pulse was followed by a single test pulse to 60 mV after a variable recovery time (⌬t) at 4 different potentials (Ϫ40, Ϫ50, Ϫ60, and Ϫ80 mV). A and B, Recovery of adult (A) and pediatric (B) I to from block at V h ϭϪ40 mV (nϭ7 and 12, respectively). Currents during the test pulse have been normalized to the amplitude of I to after a long rest. In the absence of quinidine, recovery of pediatric and adult I to was a monoexponential process, with pediatric I to recovering almost twice as slow as the adult (pediatric rec ϭ449.9Ϯ48.5 ms; adult rec ϭ291.8Ϯ26.6 ms; PϽ0.05). In the presence of 3 mol/L quinidine, recovery from block was a double-exponential process. Significant age-dependent difference was observed in the quin at this potential, with pediatric I to recovering from block more slowly than adult (adult: fast ϭ318.2Ϯ60.9 ms, quin ϭ1627.7Ϯ186.5 ms; pediatric: fast ϭ274.4Ϯ69.3 ms, quin ϭ2937.9Ϯ454.5 ms; PϽ0.05). C, Plot of rec of recovery from inactivation of pediatric and adult I to under control conditions. Data were fit using a monoexponential function. rec changed e-fold for 10.6 mV change in membrane potential for pediatric I to and e-fold for 12.7 mV for the adult current. D, Significant developmental difference was observed in the voltage dependence of I to recovery from block. Recovery from quinidine-induced block of I to got significantly faster when adult cells were depolarized (PϽ0.05). However, pediatric I to showed flat voltage dependence. *PϽ0.05.
quinidine on I K1 in human atrial myocytes, currents were evoked by pulses ranging between Ϫ100 and Ϫ20 mV from a holding potential of Ϫ40 mV. Current amplitudes were measured at the end of an 800-ms pulse. Because the nonselective current exhibits a linear current-voltage relationship over this voltage range, a p/4 post hoc leak subtraction method was used to isolate I K1 from other currents (eg, I ns ). 19 Figure 4A shows representative current traces of I K1 before and after exposure to 100 mol/L quinidine, as well as the drug-sensitive current. The currentvoltage relationship for I K1 before and after exposure to quinidine, and the quinidine-sensitive current are shown in Figure 4B .
Exposure to 100 mol/L quinidine inhibited I K1 by 47Ϯ4%. The dose-response curve for quinidine inhibition of I K1 in pediatric and adult cells is shown in Figure 4C Currents were produced by 800-ms-long pulses ranging between Ϫ40 and 60 mV from a holding potential of Ϫ40 mV. Arrow indicates current amplitude, measured at the end of the pulse. Representative currents recorded in the absence and presence of 100 mol/L quinidine, as well as quinidine-sensitive (difference) current are also shown in (A). B, Mean data showing the effect of quinidine on the current-voltage relationship for the sustained current (nϭ6 to 9). Quinidine (100 mol/L) reduced the current by 57Ϯ6% at 60 mV. The drug-sensitive current is shown in the inset (B). C and D, Effect of 100 mol/L quinidine on the nonselective cation current. C, In the presence of cesium-containing internal solution, the transient outward current was abolished 3 minutes after rupturing the cell membrane (top right corner). Currents before and after quinidine exposure were elicited by the voltage protocol shown in the top left corner of (C). Cells were held at Ϫ40, and 800-ms pulses between Ϫ100 and 60 mV were applied in 10-mV steps. Dotted lines represent zero current. D, Average current-voltage relationship showing the lack of effect of 100 mol/L quinidine on the nonselective current. Figure 4 . Effect of quinidine on I K1 . A, Currents were elicited by 800-ms-long pulses applied to voltages between Ϫ100 and Ϫ20 mV from a holding potential of Ϫ40 mV (top left). Examples of currents before and after exposure to 100 mol/L quinidine, as well as digitally subtracted drug-sensitive currents are shown. B, Averaged current-voltage relationship for the currents under control conditions and in the presence of 100 mol/L quinidine (nϭ6 to 9). Quinidine inhibited the current at Ϫ100 mV by 47Ϯ4%. The inset shows the mean currentvoltage relationship for the quinidine-sensitive (difference) current. C, Dose-response curves for quinidine block of adult and pediatric I K1 measured at Ϫ100 mV. A linear leak subtraction that incorporated a p/4 pulse protocol was used. Current amplitudes were measured at the end of the 800-ms-long pulses. Measurements were made from cells superfused with a single dose of quinidine. The smooth curves indicate the best fit of the dose response curve to the data (solid curve indicates adult; dashed curve, pediatric). The IC 50 values for quinidine block of I K1 were not significantly different between the 2 age groups (adult IC 50 ϭ42.6 mol/L; pediatric IC 50 ϭ4.1 mol/L; PϾ0.2).
Discussion
Quinidine's Interaction With Human I to Is Age-Dependent
We investigated the effects of age on the interactions of quinidine with potassium channels expressed in human atrial myocytes obtained from pediatric and adult patients. Our results indicate that there are significant developmental changes in both quinidine's affinity for human atrial I to , as well as its mechanism of unblocking. Pediatric I to had a Ϸ5-fold higher IC 50 for inhibition by quinidine compared with adult cells (PϽ0.0001; Figure 1B ). In addition, adult and pediatric cells displayed a difference in their voltage dependence of recovery from quinidine blockade, with the voltage dependence of recovery from quinidine block being slowed with hyperpolarization in adult cells and relatively independent of voltage in pediatric cells ( Figure  2D ). The voltage dependence of quinidine unblocking in adult cells seems most consistent with an activation trapping mechanism. 20, 21 According to this mechanism, the charged form of quinidine becomes trapped within the channel lumen by a closed activation gate, and recovery from block then is determined by the rate of spontaneous channel opening, which becomes progressively smaller with increasing hyperpolarization. The lack of significant voltage dependence of quinidine unblocking in pediatric cells ( Figure 2D ) suggests that either quinidine is not trapped by the activation gate or it is trapped equally at all voltages between Ϫ40 and Ϫ80 mV in pediatric cells. Additional experiments will be needed to distinguish between these possibilities. Possible explanations for the age-dependent difference in inactivation recovery kinetics and quinidine unblocking kinetics ( Figure 2C and 2D) include age-related changes in the mixture of multimeric proteins that constitute a functional channel (eg, due to subunit switching during development, as has been reported to occur between Kv1.4 and Kv4.2/4.3 in developing rat ventricular myocytes), 22 changes in posttranslational modification of the channel, or changes in the expression of an accessory subunit (eg, ␤) that modulates channel function. Further experiments will be required to distinguish between these possible mechanisms.
Effects of Quinidine on I Kur , I ns , and I K1
The lack of effect of quinidine on the nonselective component (I ns ) of the sustained current (I sus ) ( Figure 3D ) indicates that quinidine's effect on the total steady-state current in human atrial myocytes is a result of selective inhibition of I Kur . Quinidine's effect on I Kur was found to be age-independent with an IC 50 of 5 to 7 mol/L (PϾ0.76) in pediatric and adult atrial myocytes. Our study also showed that quinidine inhibited the human atrial I K1 at therapeutically relevant concentrations. Although the estimated IC 50 values for quinidine inhibition of pediatric and adult I K1 differed by a factor of 10 (IC 50 ϭ4.1 mol/L in pediatric versus IC 50 ϭ42.6 mol/L in adult), the concentration dependence of quinidine blockade was extremely shallow (Nϭ0.25 and 0.27; Figure 4C ), and the 95% confidence intervals for the estimated IC 50 values for the 2 age groups overlapped (0.07 to 25 700 mol/L in adult versus 0.0003 to 65 850 mol/L for pediatric cells). Consequently, the estimated IC 50 values for quinidine block of I K1 in pediatric and adult cells were not significantly different.
Comparison of Results With Previous Studies
Our data on the effects of age on I to sensitivity to quinidine are opposite of those reported by the study on quinidine's effects on rabbit cardiac I to , 7 suggesting the existence of species variations in the effects of antiarrhythmic drugs on I to . Interestingly, the postnatal changes in gating behavior of rabbit I to are also opposite to those observed in human atrial I to , 12, 23 indicating that significant species and/or tissue differences in the pattern of postnatal changes in ionic currents also exist.
There are conflicting reports on the effect of quinidine on the inwardly rectifying potassium current (I K1 ) in different animal species, including results suggesting both inhibition 7, 24 or lack of effect of quinidine on I K1 . [25] [26] [27] Quinidine's effect on I K1 also has been reported to be age-dependent in rabbits, with the neonatal current being more sensitive to inhibition by the quinidine when compared with the adult current. 7 However, rabbit I K1 has been shown to undergo significant developmental changes, 28, 29 whereas no such developmental changes have been demonstrated for human I K1 . 12 These results indicate that species-related differences in channel expression and the pattern of postnatal changes exist for both I to and I K1 in mammalian cardiac tissue. In support of this hypothesis, Dixon et al 30 have suggested that the Kv4.3 channel may underlie the bulk of the I to in canine and human cardiac myocytes, whereas both Kv4.2 and Kv4.3 are likely to contribute to I to in rat. A recent study also indicates that significant regional diversity of K channel expression also may exist between cells present in different areas of the heart (eg, atrial versus ventricular). 31 For this reason, extrapolation of data on the pharmacology of ion channels from one species to another, or from one region of the heart to another, should be done with caution.
A study comparing human atrial action potentials from pediatric and adult patients was the first to suggest the existence of developmental difference in the contribution of I to to action potential repolarization. 21 Later work 12, 32 demonstrated age-related differences in both the density and inactivation recovery kinetics of human atria I to , a finding confirmed by this study, as well. In contrast to the results from these 2 studies, work by Gross et al 33 suggested that the amplitude and I to inactivation recovery kinetics do not change as a function of age. The reason for the differences in the findings of these groups is unclear. Although in the study by Mansourati and Le Grand, 32 I to was recorded from cells obtained only from dilated atria, the specimens used in the study by Crumb et al, 12 as well as the tissue used in this study, came only from nondilated atria (see Materials and Methods). The lack of I to in some pediatric cells, as well as its smaller magnitude, also could contribute to the observed age-related difference in the antiarrhythmic properties of quinidine in humans.
Clinical Relevance
Clinical studies have suggested that there are age-related differences in the effectiveness of quinidine when used for the treatment of atrial arrhythmias, with quinidine being less effective in the pediatric population compared with the adult population. 10, 11 In theory, age-dependent differences in the pharmacokinetics of quinidine, as well as differences in the pharmacodynamic interaction of quinidine with heart tissue, could contribute to the clinically observed developmental differences in the antiarrhythmic effectiveness of quinidine. Previous studies have shown that quinidine is cleared by both hepatic and renal mechanisms. Approximately 60% to 85% of quinidine administered is cleared by hepatic metabolism, with hepatic clearance in pediatric patients being 2 to 3 times as rapid as the clearance in adults. 1 Renal clearance involves both glomerular filtration and active tubular secretion and accounts for 15% to 40% of total clearance. 1 When renal clearance is taken into account, the total quinidine clearance is independent of age. The plasma concentration of quinidine has been found to be significantly affected by the dose administered and by the time at which the plasma sample is obtained, but not by the age of the patients. 34 This information suggests that the difference in the antiarrhythmic effectiveness of quinidine in pediatric and adult population cannot be accounted for by an age dependence of the disposition kinetics of quinidine.
To our knowledge, this work is the first to investigate the effect of postnatal development on quinidine's interactions with human cardiac potassium channels. Potassium currents play an important role in regulating the shape of the cardiac action potential and the duration of the electrical refractory period. Our results indicate that quinidine produces significant age-related differences in its ability to inhibit the transient outward current. Developmental changes in quinidine's affinity for the transient outward current, as well as a developmental change in I to density, may contribute to the reported difference in quinidine's antiarrhythmic effectiveness in pediatric and adult patients by making pediatric tissue less sensitive to quinidine-induced changes in repolarization and refractoriness.
Quinidine was observed to inhibit the sustained outward current (I Kur ) at relatively low concentrations (IC 50 ϭ5 to 7 mol/L) and in an age-independent manner, suggesting that inhibition of this current also may contribute to its antiarrhythmic activity in both age groups. Quinidine was also observed to reduce the amplitude of I K1 by Ϸ20% to 30% at therapeutic concentrations, an effect that could contribute to drug effects on diastolic excitability. These results help to clarify the electrophysiological mechanisms by which quinidine elicits its antiarrhythmic effect in pediatric and adult patients.
